Article
N-acetyltransferase 2 acetylation polymorphism: prevalence of slow acetylators does not differ between atopic dermatitis patients and healthy subjects.
Skin pharmacology and applied skin physiology - 1 Jan 2000
Brocvielle H, Muret P, Goydadin A-C, Boone P, Broly F, Kantelip J-P, Humbert P
Abstract excerpt
The genetic polymorphism of human N-acetyltransferase 2 (NAT2) divides the human population into groups with rapid, intermediate and slow acetylator status. Slow acetylator status has been considered a predisposing factor for allergic diseases, lupus erythematosus, toxic epidermal necrolysis or Stevens-Johnson syndrome. The aim of this study was to investigate whether Caucasian patients suffering from atopic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.